Impact BioMedical, Inc.'s total assets for Q2 2026 were C$16.75M, a decrease of -2.00% from the previous quarter. IBO total liabilities were C$2.73M for the fiscal quarter, a 15.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.